The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.

Running With Théoden is a special Observer interview series featuring runs with influential Charlotteans. This week: Leigh Thomas Brown. Part of the McClatchy Media Network ...